Abstract
The pharmacokinetics of ximoprofen were studied in young and elderly subjects after single and repeated doses up to 30 mg. In healthy elderly subjects (30 mg dose), a mean peak plasma drug concentration of 1.78 micrograms ml-1 +/- 0.83 s.d. occurred at a mean time of 1.95 h +/- 1.40 s.d. and, thereafter, concentrations declined monoexponentially with a mean half-life of 3.8 h +/- 1.4 s.d. Comparison of these data with those from younger healthy subjects showed that peak drug concentrations, areas under the curve and half-lives were about two-fold greater in the elderly, these differences probably reflecting a lower systemic drug clearance. Similar results were obtained on comparing data from young healthy subjects and elderly rheumatic patients receiving single and repeated doses of ximoprofen (15 mg twice daily). In patients, the half-life of ximoprofen was 2.5 h +/- 0.7 s.d. Within either group, pharmacokinetic parameters after single or repeated doses were similar: ximoprofen did not accumulate in the plasma of the young or elderly.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Adams S. S. Non-steroidal anti-inflammatory drugs, plasma half-lives, and adverse reactions. Lancet. 1987 Nov 21;2(8569):1204–1205. doi: 10.1016/s0140-6736(87)91335-3. [DOI] [PubMed] [Google Scholar]
- Bjornsson T. D., Cocchetto D. M., McGowan F. X., Verghese C. P., Sedor F. Nomogram for estimating creatinine clearance. Clin Pharmacokinet. 1983 Jul-Aug;8(4):365–369. doi: 10.2165/00003088-198308040-00007. [DOI] [PubMed] [Google Scholar]
- Dawling S., Crome P. Clinical pharmacokinetic considerations in the elderly. An update. Clin Pharmacokinet. 1989 Oct;17(4):236–263. doi: 10.2165/00003088-198917040-00003. [DOI] [PubMed] [Google Scholar]
- Greenblatt D. J., Abernethy D. R., Matlis R., Harmatz J. S., Shader R. I. Absorption and disposition of ibuprofen in the elderly. Arthritis Rheum. 1984 Sep;27(9):1066–1069. doi: 10.1002/art.1780270918. [DOI] [PubMed] [Google Scholar]
- Hamdy R. C., Murnane B., Perera N., Woodcock K., Koch I. M. The pharmacokinetics of benoxaprofen in elderly subjects. Eur J Rheumatol Inflamm. 1982;5(2):69–75. [PubMed] [Google Scholar]
- Jamali F., Mehvar R., Pasutto F. M. Enantioselective aspects of drug action and disposition: therapeutic pitfalls. J Pharm Sci. 1989 Sep;78(9):695–715. doi: 10.1002/jps.2600780902. [DOI] [PubMed] [Google Scholar]
- Jansen P. A., van Ginneken C. A., Gribnau F. W. Is dose adjustment of non-steroidal anti-inflammatory drugs necessary in the elderly? A review of the pharmacokinetics of NSAID in the aged. Neth J Med. 1987 Jun;30(5-6):248–258. [PubMed] [Google Scholar]
- Mayo B. C., Chasseaud L. F., Hawkins D. R., Taylor I. W., Legeai J. The metabolic fate of 14C-ximoprofen in rats, baboons and humans. Xenobiotica. 1990 Mar;20(3):233–246. doi: 10.3109/00498259009046843. [DOI] [PubMed] [Google Scholar]
- Taylor I. W., Chasseaud L. F. Determination of ximoprofen in human plasma by gas chromatography. J Chromatogr. 1989 Oct 27;495:275–280. doi: 10.1016/s0378-4347(00)82632-8. [DOI] [PubMed] [Google Scholar]
- Taylor I. W., Taylor T., James I., Doyle G., Dorf G., Darragh A., Chasseaud L. F. Pharmacokinetics of the anti-inflammatory drug ximoprofen in healthy subjects and in disease states. Eur J Clin Pharmacol. 1991;40(1):101–106. doi: 10.1007/BF00315147. [DOI] [PubMed] [Google Scholar]
- Woodhouse K. W., Wynne H. The pharmacokinetics of non-steroidal anti-inflammatory drugs in the elderly. Clin Pharmacokinet. 1987 Feb;12(2):111–122. doi: 10.2165/00003088-198712020-00002. [DOI] [PubMed] [Google Scholar]